New Congenital Heart Disease Research from Mayo Clinic Described (Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease).

Předmět:	CONGENITAL heart disease PULMONARY arterial hypertension CARDIAC research MEDICAL personnel CONGENITAL disorders PULMONARY hypertension
Zdroj:	Heart Disease Weekly; 1/9/2024, p306-306, 1p
Abstrakt:	A recent report from the Mayo Clinic discusses the current management and future directions for pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). The report highlights that while current management strategies have improved the survival of patients with congenital heart disease into adulthood, there are still uncertainties regarding the long-term effects of medications on PAH-CHD patients. The aim of the review is to provide a summary of the current evidence and future perspectives on treatment strategies for PAH-CHD to guide the management of this complex disease. The report emphasizes the need for expert management and the potential benefits of novel agents in improving the quality of life and prognosis for PAH-CHD patients. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu